Restatement of Previously Issued Unaudited Condensed Financial Statements for the Six Months Ended August 31, 2021 (Details) - Schedule of the company’s previously issued balance	6 Months Ended
	Aug. 31, 2021 USD ($)
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	$ 1,564,301
Note payable	247,830
Derivative warrant liability
Common stock	7,733
Additional paid-in capital	447,905,801
Accumulated deficit	(468,006,856)
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	(185,250)
Note payable
Derivative warrant liability	1,182,314
Common stock
Additional paid-in capital	(136,004)
Total liabilities	258,636
Share-based compensation addition	84,526
Accumulated deficit	(1,182,314)
Total stockholders’ deficit	136,004
Total liabilities and stockholders’ deficit	(258,636)
Share-based compensation expense	(84,526)
Payroll compensation expense	185,250
Reclassifications [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	6,596
Note payable	(6,596)
Derivative warrant liability
Common stock	(2)
Additional paid-in capital	2
Total liabilities
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit
Share-based compensation expense
Payroll compensation expense
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	1,385,647
Note payable	241,234
Derivative warrant liability	1,182,314
Common stock	7,731
Additional paid-in capital	448,112,961
Accumulated deficit	$ (469,211,078)